Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Appelbaum, FR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 285 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Anderson, JE; Appelbaum, FR; Schoch, G; Barnett, T; Chauncey, TR; Flowers, MED; Storb, R
      Relapse alter allogeneic bone marrow transplantation for refractory anemiais increased by shielding lungs and liver during total body irradiation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    2. Storb, R; Blume, KG; O'Donnell, MR; Chauncey, T; Forman, SJ; Deeg, HJ; Hu, WW; Appelbaum, FR; Doney, K; Flowers, MED; Sanders, J; Leisenring, W
      Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in fourcenters

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    3. Appelbaum, FR
      Who should be transplanted for AML?

      LEUKEMIA
    4. Petersdorf, SH; Kopecky, KJ; Head, DR; Boldt, DH; Balcerzak, SP; Wun, T; Roy, V; Veith, RW; Appelbaum, FR
      Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblasticleukemia: a Southwest Oncology Group Study

      LEUKEMIA
    5. Bennett, CL; Hynes, D; Godwin, J; Stinson, TJ; Golub, RM; Appelbaum, FR
      Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): Estimates from a Southwest Oncology Group clinical trial

      CANCER INVESTIGATION
    6. Witherspoon, RP; Deeg, HJ; Storer, B; Anasetti, C; Storb, R; Appelbaum, FR
      Hematopoietic stern-cell transplantation for treatment-related leukemia ormyelodysplasia

      JOURNAL OF CLINICAL ONCOLOGY
    7. Morrison, VA; Rai, KR; Peterson, BL; Kolitz, JE; Elias, L; Appelbaum, FR; Hines, JD; Shepherd, L; Martell, RE; Larson, RA; Schiffer, CA
      Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011

      JOURNAL OF CLINICAL ONCOLOGY
    8. Sievers, EL; Larson, RA; Stadtmauer, EA; Estey, E; Lowenberg, B; Dombret, H; Karanes, C; Theobald, M; Bennett, JM; Sherman, ML; Berger, MS; Eten, CB; Loken, MR; van Dongen, JJM; Bernstein, ID; Appelbaum, FR
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

      JOURNAL OF CLINICAL ONCOLOGY
    9. Garrido, SM; Appelbaum, FR; Willman, CL; Banker, DE
      Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)

      EXPERIMENTAL HEMATOLOGY
    10. Gutierrez-Delgado, F; Maloney, DG; Press, OW; Golden, J; Holmberg, LA; Maziarz, RT; Hooper, H; Buckner, CD; Appelbaum, FR; Bensinger, WI
      Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens

      BONE MARROW TRANSPLANTATION
    11. Gopal, AK; Gooley, TA; Golden, JB; Maloney, DG; Bensinger, WI; Petersdorf, SH; Appelbaum, FR; Press, OW
      Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older

      BONE MARROW TRANSPLANTATION
    12. Garrido, SM; Cooper, JJ; Appelbaum, FR; Willman, CL; Kopecky, K; Banker, DE
      Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis

      LEUKEMIA RESEARCH
    13. Appelbaum, FR
      Perspectives on the future of chronic myeloid leukemia treatment

      SEMINARS IN HEMATOLOGY
    14. Bensinger, WI; Storer, B; Appelbaum, FR
      Hematopoietic reconstitution by transplantation of stem cells from bone marrow or blood. Reply

      NEW ENGLAND JOURNAL OF MEDICINE
    15. Deeg, HJ; Appelbaum, FR
      Stem-cell transplantation for myelofibrosis.

      NEW ENGLAND JOURNAL OF MEDICINE
    16. Appelbaum, FR
      Haematopoietic cell transplantation as immunotherapy

      NATURE
    17. Appelbaum, FR
      Gemtuzumab ozogamicin - Viewpoint

      DRUGS
    18. Al-Ghamdi, H; Leisenring, W; Bensinger, WI; Nash, RA; Storb, R; Appelbaum, FR; Martin, PJ
      A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest

      BRITISH JOURNAL OF HAEMATOLOGY
    19. Jurado, M; Deeg, HJ; Gooley, T; Anasetti, C; Chauncey, T; Flowers, MED; Myerson, D; Storb, R; Appelbaum, FR
      Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    20. Radich, JP; Gooley, T; Bryant, E; Chauncey, T; Clift, R; Beppu, L; Edmands, S; Flowers, MED; Kerkof, K; Nelson, R; Appelbaum, FR
      The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation

      BLOOD
    21. Linenberger, ML; Hong, T; Flowers, D; Sievers, EL; Gooley, TA; Bennett, JM; Berger, MS; Leopold, LH; Appelbaum, FR; Bernstein, ID
      Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin

      BLOOD
    22. Anderson, JE; Tefferi, A; Craig, F; Holmberg, L; Chauncey, T; Appelbaum, FR; Guardiola, P; Callander, N; Freytes, C; Gazitt, Y; Razvillas, B; Deeg, HJ
      Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia withmyelofibrosis

      BLOOD
    23. Storek, J; Joseph, A; Espino, G; Dawson, MA; Douek, DC; Sullivan, KM; Flowers, MED; Martin, P; Mathioudakis, G; Nash, RA; Storb, R; Appelbaum, FR; Maloney, DG
      Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation

      BLOOD
    24. Kansu, E; Gooley, T; Flowers, MED; Anasetti, C; Deeg, HJ; Nash, RA; Sanders, JE; Witherspoon, RP; Appelbaum, FR; Storb, R; Martin, PJ
      Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial

      BLOOD
    25. List, AF; Kopecky, KJ; Willman, CL; Head, DR; Persons, DL; Slovak, ML; Dorr, R; Karanes, C; Hynes, HE; Doroshow, JH; Shurafa, M; Appelbaum, FR
      Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

      BLOOD
    26. Li, ZH; Gooley, T; Appelbaum, FR; Deeg, HJ
      Splenectomy and hemopoietic stem cell transplantation for myelofibrosis

      BLOOD
    27. Storek, J; Dawson, MA; Storer, B; Stevens-Ayers, T; Maloney, DG; Marr, KA; Witherspoon, RP; Bensinger, W; Flowers, MED; Martin, P; Storb, R; Appelbaum, FR; Boeckh, M
      Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

      BLOOD
    28. McSweeney, PA; Niederwieser, D; Shizuru, JA; Sandmaier, BM; Molina, AJ; Maloney, DG; Chauncey, TR; Gooley, TA; Hegenbart, U; Nash, RA; Radich, J; Wagner, JL; Minor, S; Appelbaum, FR; Bensinger, WI; Bryant, E; Flowers, MED; Georges, GE; Grumet, FC; Kiem, HP; Torok-Storb, B; Yu, G; Blume, KG; Storb, RF
      Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

      BLOOD
    29. Stirewalt, DL; Kopecky, KJ; Meshinchi, S; Appelbaum, FR; Slovak, ML; Willman, CL; Radich, JP
      FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia

      BLOOD
    30. Tallman, MS; Andersen, JW; Schiffer, CA; Appelbaum, FR; Feusner, JH; Ogden, A; Shepherd, L; Willman, C; Bloomfield, CD; Rowe, JM; Wiernik, PH
      All-trans-retinoic acid maintenance for acute promyelocytic leukemia

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    31. Witherspoon, RP; Deeg, HJ; Storb, R; Appelbaum, FR; Hutchinson, F
      Secondary leukemia or myelodysplasia treated by bone marrow transplantation

      ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES
    32. Flowers, MED; Leisenring, W; Beach, K; Riddell, S; Radich, JP; Higano, CS; Rowley, SD; Chauncey, TR; Bensinger, WI; Sanders, JE; Anasetti, C; Storb, R; Wade, J; Appelbaum, FR; Martin, PJ
      Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion forrecurrent chronic myeloid leukemia after bone marrow transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    33. Radich, JP; Gooley, T; Sanders, JE; Anasetti, C; Chauncey, T; Appelbaum, FR
      Second allogeneic transplantation after failure of first autologous transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    34. Appelbaum, FR
      Dedication

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    35. Nash, RA; Kurzrock, R; DiPersio, J; Vose, J; Linker, C; Maharaj, D; Nademanee, AP; Negrin, R; Nimer, S; Shulman, H; Ashby, M; Jones, D; Appelbaum, FR; Champlin, R
      A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    36. Crump, C; Chen, C; Appelbaum, FR; Kopecky, KJ; Schwartz, SM; Willman, CL; Slovak, ML; Weiss, NS
      Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    37. Zhang, FF; Murata-Collins, JL; Gaytan, P; Forman, SJ; Kopecky, KJ; Willman, CL; Appelbaum, FR; Slovak, ML
      Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia

      GENES CHROMOSOMES & CANCER
    38. Deeg, HJ; Appelbaum, FR
      Hemopoietic stem cell transplantation for myelodysplastic syndrome

      CURRENT OPINION IN ONCOLOGY
    39. O'Donnell, MR; Appelbaum, FR; Baer, MR; Carabasi, MH; Coutre, SE; Erba, HP; Estey, E; Glenn, MJ; Kraut, EH; Maslak, P; Millenson, M; Miller, CB; Saba, HI; Stone, R; Tallman, MS
      NCCN Practice Guidelines for acute myelogenous leukemia

      ONCOLOGY-NEW YORK
    40. Appelbaum, FR
      Is there a best transplant conditioning regimen for acute myeloid leukemia?

      LEUKEMIA
    41. Furlong, T; Storb, R; Anasetti, C; Appelbaum, FR; Deeg, HJ; Doney, K; Martin, P; Sullivan, K; Witherspoon, R; Nash, RA
      Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acutegraft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities

      BONE MARROW TRANSPLANTATION
    42. Koc, S; Hagglund, H; Ireton, RC; Perez-Simon, JA; Collins, SJ; Appelbaum, FR
      Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation

      BONE MARROW TRANSPLANTATION
    43. Sierra, J; Storer, B; Hansen, JA; Martin, PJ; Petersdorf, EW; Woolfrey, A; Matthews, D; Sanders, JE; Storb, R; Appelbaum, FR; Anasetti, C
      Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience

      BONE MARROW TRANSPLANTATION
    44. Gutierrez-Delgado, F; Holmberg, LA; Hooper, H; Appelbaum, FR; Livingston, RB; Maziarz, RT; Weiden, P; Rivkin, S; Montgomery, P; Kawahara, K; Bensinger, W
      High-dose busulfan, melphalan and thiotepa as consolidation for noninflammatory high-risk breast cancer

      BONE MARROW TRANSPLANTATION
    45. Cavallaro, AM; Lilleby, K; Majolino, I; Storb, R; Appelbaum, FR; Rowley, SD; Bensinger, WI
      Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor

      BONE MARROW TRANSPLANTATION
    46. Garrido, SM; Willman, C; Appelbaum, FR; Banker, DE
      Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples

      CYTOMETRY
    47. Chauncey, TR; Rankin, C; Anderson, JE; Chen, IM; Kopecky, KJ; Godwin, JE; Kalaycio, ME; Moore, DF; Shurafa, MS; Petersdorf, SH; Kraut, EH; Leith, CP; Head, DR; Luthardt, FW; Willman, CL; Appelbaum, FR
      A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and theMDR modulator PSC 833: a Southwest Oncology Group study 9617

      LEUKEMIA RESEARCH
    48. Garrido, SM; Bryant, E; Appelbaum, FR
      Allogeneic stem cell transplantation for relapsed and refractory acute myeloid leukemia patients with 11q23 abnormalities

      LEUKEMIA RESEARCH
    49. Rosen, PJ; Rankin, C; Head, DR; Boldt, DH; Luthardt, FW; Norwood, T; Pugh, RP; Karanes, C; Appelbaum, FR
      A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia

      LEUKEMIA RESEARCH
    50. Rai, KR; Peterson, BL; Appelbaum, FR; Kolitz, J; Elias, L; Shepherd, L; Hines, J; Threatte, GA; Larson, RA; Cheson, BD; Schiffer, CA
      Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.

      NEW ENGLAND JOURNAL OF MEDICINE
    51. Press, OW; Eary, JF; Gooley, T; Gopal, AK; Liu, S; Rajendran, JG; Maloney, DG; Petersdorf, S; Bush, SA; Durack, LD; Martin, PJ; Fisher, DR; Wood, B; Borrow, JW; Porter, B; Smith, JP; Matthews, DC; Appelbaum, FR; Bernstein, ID
      A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas

      BLOOD
    52. Deeg, HJ; Flowers, MED; Leisenring, W; Appelbaum, FR; Martin, PJ; Storb, RF
      Cyclosporine (CSP) or CSP pins methylprednisolone for graft-versus-host-disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial

      BLOOD
    53. Slovak, ML; Kopecky, KJ; Cassileth, PA; Harrington, DH; Theil, KS; Mohamed, A; Paietta, E; Willman, CL; Head, DR; Rowe, JM; Forman, SJ; Appelbaum, FR
      Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

      BLOOD
    54. Koc, S; Leisenring, W; Flowers, MED; Anasetti, C; Deeg, HJ; Nash, RA; Sanders, JE; Witherspoon, RP; Appelbaum, FR; Storb, R; Martin, PJ
      Thalidomide for treatment of patients with chronic graft-versus-host disease

      BLOOD
    55. Deeg, HJ; Shulman, HM; Anderson, JE; Bryant, EM; Gooley, TA; Slattery, JT; Anasetti, C; Fefer, A; Storb, R; Appelbaum, FR
      Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

      BLOOD
    56. Tallman, MS; Andersen, JW; Schiffer, CA; Appelbaum, FR; Feusner, JH; Ogden, A; Shepherd, L; Rowe, JM; Francois, C; Larson, RS; Wiernik, PH
      Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome

      BLOOD
    57. Appelbaum, FR
      Mechanisms of cure of acute myeloid leukemia with allogeneic transplantation

      HEMATOPOIETIC STEM CELL TRANSPLANTION
    58. Li, Q; Kopecky, KJ; Mohan, A; Willman, CL; Appelbaum, FR; Weick, JK; Issa, JPJ
      Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia

      CLINICAL CANCER RESEARCH
    59. Stirewalt, DL; Clurman, B; Appelbaum, FR; Willman, CL; Radich, JP
      P73 mutations and expression in adult de novo acute myelogenous leukemia

      LEUKEMIA
    60. Karanes, C; Kopecky, KJ; Head, DR; Grever, MR; Hynes, HE; Kraut, EH; Vial, RH; Lichtin, A; Nand, S; Samlowski, WE; Appelbaum, FR
      A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia

      LEUKEMIA RESEARCH
    61. Appelbaum, FR
      Molecular diagnosis and clinical decisions in adult acute leukemia

      SEMINARS IN HEMATOLOGY
    62. Cassileth, PA; Appelbaum, FR; Wiernik, PH
      Treatment of acute myeloid leukemia - Reply

      NEW ENGLAND JOURNAL OF MEDICINE
    63. Martin, PJ; Rowley, SD; Anasetti, C; Chauncey, TR; Gooley, T; Petersdorf, EW; van Burik, J; Flowers, MED; Storb, R; Appelbaum, FR; Hansen, JA
      A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients

      BLOOD
    64. Silver, RT; Woolf, SH; Hehlmann, R; Appelbaum, FR; Anderson, J; Bennett, C; Goldman, JM; Guilhot, F; Kantarjian, HM; Lichtin, AE; Talpaz, M; Tura, S
      An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology

      BLOOD
    65. Matthews, DC; Appelbaum, FR; Eary, JF; Fisher, DR; Durack, LD; Hui, TE; Martin, PJ; Mitchell, D; Press, OW; Storb, R; Bernstein, ID
      Phase I study of I-131-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome

      BLOOD
    66. Leith, CP; Kopecky, KJ; Chen, IM; Eijdems, L; Slovak, ML; McConnell, TS; Head, DR; Weick, J; Grever, MR; Appelbaum, FR; Willman, CL
      Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study

      BLOOD
    67. Appelbaum, FR
      Choosing the source of stem cells for allogeneic transplantation: No longer a peripheral issue

      BLOOD
    68. Holmberg, LA; Boeckh, M; Hooper, H; Leisenring, W; Rowley, S; Heimfeld, S; Press, O; Maloney, DG; McSweeney, P; Corey, L; Maziarz, RT; Appelbaum, FR; Bensinger, W
      Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation

      BLOOD
    69. Clift, RA; Radich, J; Appelbaum, FR; Martin, P; Flowers, MED; Deeg, HJ; Storb, R; Thomas, ED
      Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic phase of chronic myeloid leukemia

      BLOOD
    70. Matthews, DC; Martin, PJ; Nourigat, C; Appelbaum, FR; Fisher, DR; Bernstein, ID
      Marrow ablative and immunosuppressive effects of I-131-anti-CD45 antibody in congenic and H2-mismatched murine transplant models

      BLOOD
    71. Gibbs, JP; Gooley, T; Corneau, B; Murray, G; Stewart, P; Appelbaum, FR; Slattery, JT
      The impact of obesity and disease on busulfan oral clearance in adults

      BLOOD
    72. Sievers, EL; Appelbaum, FR; Spielberger, RT; Forman, SJ; Flowers, D; Smith, FO; Shannon-Dorcy, K; Berger, MS; Bernstein, ID
      Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: A phase I study of an anti-CD33 calicheamicin immunoconjugate

      BLOOD
    73. Banker, DE; Radich, J; Becker, A; Kerkof, K; Norwood, T; Willman, C; Appelbaum, FR
      The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults

      CLINICAL CANCER RESEARCH
    74. APPELBAUM FR; ANDERSON J
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME -OUTCOMES ANALYSIS ACCORDING TO IPSS SCORE

      Leukemia
    75. LIU SY; EARY JF; PETERSDORF SH; MARTIN PJ; MALONEY DG; APPELBAUM FR; MATTHEWS DC; BUSH SA; DURACK LD; FISHER DR; GOOLEY TA; BERNSTEIN ID; PRESS OW
      FOLLOW-UP OF RELAPSED B-CELL LYMPHOMA PATIENTS TREATED WITH IODINE-131-LABELED ANTI-CD20 ANTIBODY AND AUTOLOGOUS STEM-CELL RESCUE

      Journal of clinical oncology
    76. STORB R; RAFF R; DEEG HJ; GRAHAM T; APPELBAUM FR; SCHUENING FG; SHULMAN H; SEIDEL K; LEISENRING W
      DOSE RATE-DEPENDENT SPARING OF THE GASTROINTESTINAL-TRACT BY FRACTIONATED TOTAL-BODY IRRADIATION IN DOGS GIVEN MARROW AUTOGRAFTS

      International journal of radiation oncology, biology, physics
    77. HOLMBERG LA; DEMIRER T; ROWLEY S; BUCKNER CD; GOODMAN G; MAZIARZ R; KLARNET J; ZUCKERMAN N; HARRER G; MCCLOSKEY R; GERSH R; GOLDBERG R; NICHOLS W; JACOBS A; WEIDEN P; MONTGOMERY P; RIVKIN S; APPELBAUM FR; BENSINGER WI
      HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) RESCUE IN PATIENTS WITH ADVANCED-STAGE III IV OVARIAN-CANCER/

      Bone marrow transplantation
    78. BANKER DE; GROUDINE M; WILLMAN CL; NORWOOD T; APPELBAUM FR
      CELL-CYCLE PERTURBATIONS IN ACUTE MYELOID-LEUKEMIA SAMPLES FOLLOWING IN-VITRO EXPOSURES TO THERAPEUTIC AGENTS

      Leukemia research
    79. APPELBAUM FR; ANDERSON J
      BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA IN ADULTS AND CHILDREN- WHEN AND WHO

      Leukemia research
    80. TALLMAN MS; APPELBAUM FR; SCHIFFER CA
      ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA - REPLY

      The New England journal of medicine
    81. Cassileth, PA; Harrington, DP; Appelbaum, FR; Lazarus, HM; Rowe, JM; Paietta, E; Willman, C; Hurd, DD; Bennett, JM; Blume, KG; Head, DR; Wiernik, PH
      Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

      NEW ENGLAND JOURNAL OF MEDICINE
    82. REN S; KALHORN TF; MCDONALD GB; ANASETTI C; APPELBAUM FR; SLATTERY JT
      PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND ITS METABOLITES IN BONE-MARROW TRANSPLANTATION PATIENTS

      Clinical pharmacology and therapeutics
    83. CLIFT RA; BUCKNER CD; APPELBAUM FR; SULLIVAN KM; STORB R; THOMAS ED
      LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF 2 IRRADIATION REGIMENS FOR PATIENTS RECEIVING ALLOGENEIC MARROW TRANSPLANTS DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA

      Blood
    84. MORTON AJ; GOOLEY T; HANSEN JA; APPELBAUM FR; BRUEMMER B; BJERKE JW; CLIFT R; MARTIN PJ; PETERSDORF EW; SANDERS JE; STORB R; SULLIVAN KM; WOOLFREY A; ANASETTI C
      ASSOCIATION BETWEEN PRETRANSPLANT INTERFERON-ALPHA AND OUTCOME AFTER UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

      Blood
    85. APPELBAUM FR; KOPECKY KJ; WILLMAN CL
      RESPONSE - SENSITIVE AND SPECIFIC ASSESSMENT OF MDR1 IS ESSENTIAL TO DETERMINE PROGNOSTIC IMPACT IN AML

      Blood
    86. WOOLFREY AE; GOOLEY TA; SIEVERS EL; MILNER LA; ANDREWS RG; WALTERS M; HOFFMEISTER P; HANSEN JA; ANASETTI C; BRYANT E; APPELBAUM FR; SANDERS JE
      BONE-MARROW TRANSPLANTATION FOR CHILDREN LESS-THAN 2 YEARS OF AGE WITH ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROME

      Blood
    87. SANDMAIER BM; STORB R; BENNETT KL; APPELBAUM FR; SANTOS EB
      EPITOPE SPECIFICITY OF CD44 FOR MONOCLONAL ANTIBODY-DEPENDENT FACILITATION OF MARROW ENGRAFTMENT IN A CANINE MODEL

      Blood
    88. GODWIN JE; KOPECKY KJ; HEAD DR; WILLMAN CL; LEITH CP; HYNES HE; BALCERZAK SP; APPELBAUM FR
      A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY (9031)

      Blood
    89. SIEVERS EL; BERNSTEIN ID; SPIELBERGER RT; FORMAN SJ; SHANNONDORCY K; APPELBAUM FR
      TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID-LEUKEMIA (AML) WITH RECOMBINANT ENGINEERED HUMAN ANTI-CD33 ANTIBODY-CALICHEAMICIN DRUG CONJUGATE

      European journal of cancer
    90. DEMIRER T; BUCKNER CD; STORER B; LILLEBY K; ROWLEY S; CLIFT R; APPELBAUM FR; STORB R; BENSINGER WI
      EFFECT OF DIFFERENT CHEMOTHERAPY REGIMENS ON PERIPHERAL-BLOOD STEM-CELL COLLECTIONS IN PATIENTS WITH BREAST-CANCER RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR

      Journal of clinical oncology
    91. APPELBAUM FR
      ALLOGENEIC STEM-CELL TRANSPLANTATION FOR THE TREATMENT OF HEMATOLOGICMALIGNANCIES - CURRENT INDICATIONS AND CHALLENGES

      Journal of rheumatology
    92. SCHUENING FG; VONKALLE C; KIEM HP; APPELBAUM FR; DEEG HJ; PEPE M; GOOLEY T; GRAHAM TC; HACKMAN RC; STORB R
      EFFECT OF RECOMBINANT CANINE STEM-CELL FACTOR, A C-KIT LIGAND, ON HEMATOPOIETIC RECOVERY AFTER DLA-IDENTICAL LITTERMATE MARROW TRANSPLANTS IN DOGS

      Experimental hematology
    93. ROBINSON N; BENYUNES MC; THOMPSON JA; YORK A; PETERSDORF S; PRESS O; LINDGREN C; CHAUNCEY T; BUCKNER CD; BENSINGER WI; APPELBAUM FR; FEFER A
      INTERLEUKIN-2 AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCY - A PHASE I II STUDY/

      Bone marrow transplantation
    94. BENSINGER WI; SCHIFFMAN KS; HOLMBERG L; APPELBAUM FR; MAZIARZ R; MONTGOMERY P; ELLIS E; RIVKIN S; WEIDEN P; LILLEBY K; ROWLEY S; PETERSDORF S; KLARNET JP; NICHOLS W; HERTLER A; MCCROSKEY R; WEAVER CH; BUCKNER CD
      HIGH-DOSE BUSULFAN, MELPHALAN, THIOTEPA AND PERIPHERAL-BLOOD STEM-CELL INFUSION FOR THE TREATMENT OF METASTATIC BREAST-CANCER

      Bone marrow transplantation
    95. APPELBAUM FR
      ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR ACUTE-LEUKEMIA

      Seminars in oncology
    96. TALLMAN MS; ANDERSEN JW; SCHIFFER CA; APPELBAUM FR; FEUSNER JH; OGDEN A; SHEPHERD L; WILLMAN C; BLOOMFIELD CD; ROWE JM; WIERNIK PH
      ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA

      The New England journal of medicine
    97. APPELBAUM FR; KOPECKY KJ
      LONG-TERM SURVIVAL AFTER CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA - THE EXPERIENCE OF THE SOUTHWEST-ONCOLOGY-GROUP

      Cancer
    98. ANDERSON JE; SALE G; APPELBAUM FR; CHAUNCEY TR; STORB R
      ALLOGENEIC MARROW TRANSPLANTATION FOR PRIMARY MYELOFIBROSIS AND MYELOFIBROSIS SECONDARY TO POLYCYTHEMIA-VERA OR ESSENTIAL THROMBOCYTOSIS

      British Journal of Haematology
    99. SIERRA J; RADICH J; HANSEN JA; MARTIN PJ; PETERSDORF EW; BJERKE J; BRYANT E; NASH RA; SANDERS JE; STORB R; SULLIVAN KM; APPELBAUM FR; ANASETTI C
      MARROW TRANSPLANTS FROM UNRELATED DONORS FOR TREATMENT OF PHILADELPHIA-CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA

      Blood
    100. GALLAGHER RE; WILLMAN CL; SLACK JL; ANDERSEN JW; LI YP; VISWANATHA D; BLOOMFIELD CD; APPELBAUM FR; SCHIFFER CA; TALLMAN MS; WIERNIK PH
      ASSOCIATION OF PML-RAR-ALPHA FUSION MESSENGER-RNA TYPE WITH PRETREATMENT HEMATOLOGIC CHARACTERISTICS BUT NOT TREATMENT OUTCOME IN ACUTE PROMYELOCYTIC LEUKEMIA - AN INTERGROUP MOLECULAR STUDY

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 04:04:38